Wire Stories

Ideon Technologies Announces Dr. Alan Bye as Advisor

VANCOUVER, British Columbia--(BUSINESS WIRE)--#cleantech--Ideon Technologies is pleased to announce that Dr. Alan Bye, PhD has…

Asia Pacific Embedded Payment Markets and Investment Opportunities Report 2022: Market is Expected to Grow by 41.8% to Reach $54.29 Billion in 2022 – Forecast to 2029 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Embedded Payment Business and Investment Opportunities - Q1 2022 Update" report…

Pherecydes Pharma Extends Its Intellectual Property in China With a First Patent Granted for Its anti-Pseudomonas aeruginosa Phages in This Territory

NANTES, France--(BUSINESS WIRE)--Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 – ALPHE), a biotechnology company specializing in…

Postcard Game Studio Secures $3.5 Million Seed Investment from Smilegate

New AAA Game Studio comprised of Naughty Dog, Bungie, Guerrilla Games, and 343 Industries Veterans…

Cega Raises $4.3M from Dragonfly, Pantera to Build the First Exotic Structured Products in Cryptocurrency

SINGAPORE--(BUSINESS WIRE)--#cega--Cega Finance (“Cega”), the first decentralized finance (“DeFi”) exotic structured products protocol, announced today…

Clearlake Capital-Backed Dude Solutions Rebrands to Brightly Software

New brand reflects Company’s vision to leverage software and data to power smarter assets and…

Atlas Announces Market Expansion and Sustainability Plans, as the Company Doubles Down on Web 3.0

Plans include achieving 3X geographical expansion and 100% green energy by 2024 SINGAPORE--(BUSINESS WIRE)--#Blockchain--Atlas Technology…

8×8 XCaaS™ Achieves Another Industry First; Now Delivers Integrated Cloud Contact Center and Phone Solutions for Multinational Companies in Indonesia

Now Available in Indonesia and Thailand; Offers Highest Quality of Service and Reliability for Employees…

Appen Invests in Synthetic Data Business Mindtech

As the leader in data for the AI lifecycle, Appen is investing in emerging training…

Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

SYDNEY--(BUSINESS WIRE)--#Covid19--Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma…